VRTX Vertex Pharmaceuticals Incorporated logo

VRTX Vertex Pharmaceuticals Incorporated

Healthcare
$434.52+0.23%ClosedMarket Cap: $110.28B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

19

Dispositions

8

Buy/Sell Ratio

2.38

Net Shares

+9,899

Shares Acquired

22,073

Shares Disposed

12,174

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19Bunnage Mark E.officer: EVP, Chief Scientific OfficerSell33$453.457,284
Tue May 19Bozic Carmenofficer: EVP and CMOSell1,354$453.4524,734
Thu May 14Bozic Carmenofficer: EVP and CMOSell6,988$450.0026,088
Tue May 05Upadhyay SuketudirectorSell796$0.001,558
Tue May 05Upadhyay SuketudirectorSell2,866$424.452,866
Tue May 05Upadhyay SuketudirectorSell796$0.003,595
Tue May 05Thornberry NancydirectorSell398$0.002,109
Tue May 05Thornberry NancydirectorSell1,433$424.451,433
Tue May 05Thornberry NancydirectorSell472$0.002,507
Tue May 05Thornberry NancydirectorSell398$0.00398
Tue May 05Schneider JenniferdirectorSell796$0.001,394
Tue May 05Schneider JenniferdirectorSell1,433$424.451,433
Tue May 05Schneider JenniferdirectorSell472$0.002,190
Fri Apr 17Upadhyay SuketudirectorSell81$0.002,799
Fri Apr 17SACHS BRUCE IdirectorSell107$0.0015,672